Tadapox RSM Enterprises

£36.00

Tadapox RSM Enterprises is a pharmaceutical research reference containing tadalafil and dapoxetine, designed for in-vitro laboratory studies examining dual-mechanism compounds and their molecular interactions in controlled research environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Tadapox RSM Enterprises
Tadapox RSM Enterprises
£36.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

About Tadapox RSM Enterprises

Tadapox RSM Enterprises is a pharmaceutical research reference combining tadalafil and dapoxetine, manufactured by RSM Enterprises for laboratory investigation purposes. This dual-compound formulation enables researchers to study the molecular interactions between phosphodiesterase type 5 (PDE5) inhibition and selective serotonin reuptake inhibition (SSRI) mechanisms within controlled experimental settings. Scientists examining combination pharmacology can utilise this reference material to investigate synergistic effects, bioavailability profiles, and molecular stability parameters through rigorous in-vitro analysis protocols.

Research institutions studying erectile dysfunction and premature ejaculation pathways rely on such reference standards to understand compound interactions at the cellular level. The combination allows for comprehensive investigation into dual-mechanism pharmaceutical approaches, providing valuable data for academic research into vascular biology and neurotransmitter modulation. When conducting studies on compound bioactivity, researchers at Stroid UK Shop can access high-quality reference materials alongside our extensive erection drugs collection, as well as our popular SARMs and peptides for comprehensive research programmes.

Laboratory Investigation Parameters

Research applications for this pharmaceutical reference include analytical method development, stability testing under various environmental conditions, and comparative bioavailability studies. Laboratory teams investigating combination therapies can examine how tadalafil’s PDE5 inhibition mechanisms interact with dapoxetine’s serotonin reuptake inhibition properties in cellular assays. The formulation provides standardised material for developing analytical protocols, validating detection methods, and establishing reference curves for quantitative analysis.

Academic researchers studying vascular biology and neurochemistry can utilise this reference to investigate dose-response relationships, metabolic pathways, and cellular uptake mechanisms. Quality control laboratories require authentic reference standards to validate analytical methods and ensure accurate compound identification in pharmaceutical research applications. The dual-compound nature enables comprehensive investigation into combination drug delivery systems and their respective pharmacokinetic profiles.

Technical Specifications

Tadapox RSM Enterprises Research Reference Specifications
Parameter Specification
Product Code EU11199
Manufacturer RSM Enterprises
Primary Components Tadalafil + Dapoxetine
Intended Use In-vitro research only
Storage Requirements Room temperature, dry environment
Research Applications Pharmaceutical analysis, method development

Research Compliance Statement

Tadapox RSM Enterprises is supplied exclusively for in-vitro laboratory research purposes and analytical method development. This pharmaceutical reference material is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate safety protocols, proper storage conditions, and compliance with institutional research guidelines when handling this reference standard. All studies should be conducted under appropriate laboratory supervision with suitable analytical equipment and safety measures in place.

Related